Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tumor Suppressor Protein p53 | 13 | 2017 | 2984 | 1.890 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 7 | 2017 | 387 | 1.530 |
Why?
|
| Proto-Oncogene Proteins c-abl | 5 | 2006 | 159 | 1.230 |
Why?
|
| Proto-Oncogene Proteins | 7 | 2017 | 4696 | 0.960 |
Why?
|
| Nuclear Proteins | 8 | 2017 | 5992 | 0.880 |
Why?
|
| Arsenic | 2 | 2014 | 314 | 0.700 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2016 | 2067 | 0.600 |
Why?
|
| Glycolysis | 3 | 2015 | 815 | 0.590 |
Why?
|
| DNA-Binding Proteins | 6 | 2015 | 9802 | 0.530 |
Why?
|
| Radiation-Protective Agents | 1 | 2014 | 99 | 0.500 |
Why?
|
| Genes, Tumor Suppressor | 3 | 2014 | 1101 | 0.460 |
Why?
|
| Metabolism | 1 | 2014 | 213 | 0.460 |
Why?
|
| Oncogene Proteins, Fusion | 3 | 2006 | 1588 | 0.460 |
Why?
|
| Radiation Tolerance | 2 | 2014 | 514 | 0.410 |
Why?
|
| Bystander Effect | 1 | 2009 | 81 | 0.370 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 3 | 2006 | 275 | 0.370 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2017 | 1628 | 0.370 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2015 | 8733 | 0.360 |
Why?
|
| Transfection | 9 | 2015 | 6193 | 0.360 |
Why?
|
| Transcription, Genetic | 4 | 2017 | 7988 | 0.350 |
Why?
|
| Melanoma | 2 | 2017 | 5503 | 0.330 |
Why?
|
| Fibroblasts | 6 | 2009 | 4312 | 0.330 |
Why?
|
| DNA Damage | 4 | 2008 | 2455 | 0.330 |
Why?
|
| 14-3-3 Proteins | 1 | 2008 | 223 | 0.320 |
Why?
|
| Wiskott-Aldrich Syndrome Protein Family | 1 | 2006 | 39 | 0.310 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2005 | 145 | 0.290 |
Why?
|
| Cytoplasm | 2 | 2008 | 1643 | 0.290 |
Why?
|
| Cell Line, Tumor | 9 | 2017 | 17087 | 0.290 |
Why?
|
| Phosphorylation | 7 | 2017 | 8737 | 0.290 |
Why?
|
| Radiation, Ionizing | 2 | 2005 | 277 | 0.280 |
Why?
|
| Transcription Factors | 2 | 2015 | 11982 | 0.270 |
Why?
|
| Cell Nucleus | 4 | 2017 | 3030 | 0.270 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2006 | 303 | 0.270 |
Why?
|
| Histones | 1 | 2015 | 2585 | 0.270 |
Why?
|
| Chromatin | 1 | 2015 | 2683 | 0.250 |
Why?
|
| I-kappa B Proteins | 1 | 2002 | 240 | 0.220 |
Why?
|
| Plasmids | 5 | 2007 | 2516 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2008 | 2595 | 0.210 |
Why?
|
| Phosphoserine | 2 | 2017 | 222 | 0.210 |
Why?
|
| Ubiquitin | 2 | 2003 | 848 | 0.210 |
Why?
|
| Leukemia | 2 | 2006 | 1504 | 0.210 |
Why?
|
| Protein Structure, Tertiary | 5 | 2008 | 4056 | 0.210 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2005 | 569 | 0.210 |
Why?
|
| Protein Binding | 6 | 2014 | 9694 | 0.200 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2007 | 1852 | 0.200 |
Why?
|
| NF-kappa B | 2 | 2014 | 2559 | 0.190 |
Why?
|
| Apoptosis | 4 | 2005 | 10133 | 0.190 |
Why?
|
| Promoter Regions, Genetic | 4 | 2015 | 6077 | 0.190 |
Why?
|
| Amino Acid Motifs | 3 | 2008 | 977 | 0.190 |
Why?
|
| Protein Transport | 3 | 2017 | 2052 | 0.180 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 9584 | 0.170 |
Why?
|
| Cell Cycle Proteins | 3 | 2017 | 3513 | 0.170 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2008 | 3025 | 0.170 |
Why?
|
| Mice, Nude | 2 | 2015 | 3895 | 0.160 |
Why?
|
| Cell Line | 7 | 2015 | 16795 | 0.160 |
Why?
|
| Mice | 11 | 2016 | 80950 | 0.160 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 12468 | 0.150 |
Why?
|
| Breast | 1 | 2005 | 1781 | 0.150 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 5349 | 0.150 |
Why?
|
| HEK293 Cells | 2 | 2016 | 4334 | 0.150 |
Why?
|
| Cell Membrane | 1 | 2006 | 3924 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2005 | 4976 | 0.150 |
Why?
|
| Protein Isoforms | 2 | 2015 | 1720 | 0.150 |
Why?
|
| Cisplatin | 2 | 2017 | 1663 | 0.140 |
Why?
|
| Protein Stability | 1 | 2017 | 567 | 0.140 |
Why?
|
| Blotting, Western | 4 | 2005 | 5508 | 0.140 |
Why?
|
| Signal Transduction | 2 | 2017 | 23985 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2016 | 342 | 0.130 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2017 | 738 | 0.130 |
Why?
|
| Animals | 13 | 2016 | 170647 | 0.120 |
Why?
|
| HCT116 Cells | 1 | 2014 | 413 | 0.120 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2017 | 683 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2016 | 535 | 0.120 |
Why?
|
| Whole-Body Irradiation | 1 | 2014 | 458 | 0.120 |
Why?
|
| Zinc Fingers | 1 | 2015 | 598 | 0.120 |
Why?
|
| Precipitin Tests | 2 | 2003 | 900 | 0.110 |
Why?
|
| Lentivirus | 1 | 2015 | 547 | 0.110 |
Why?
|
| src Homology Domains | 2 | 2003 | 374 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 1728 | 0.110 |
Why?
|
| Acetylation | 1 | 2015 | 1127 | 0.110 |
Why?
|
| Subcellular Fractions | 2 | 2003 | 576 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2015 | 4090 | 0.110 |
Why?
|
| Stromal Cells | 2 | 2009 | 1385 | 0.110 |
Why?
|
| Retroviridae | 2 | 2005 | 958 | 0.110 |
Why?
|
| Binding Sites | 2 | 2015 | 6335 | 0.100 |
Why?
|
| Neoplasm Transplantation | 1 | 2015 | 2190 | 0.100 |
Why?
|
| Breast Neoplasms | 2 | 2009 | 19798 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 3 | 2003 | 6659 | 0.100 |
Why?
|
| Genes, p53 | 2 | 2003 | 775 | 0.100 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 613 | 0.100 |
Why?
|
| MAP Kinase Signaling System | 2 | 2008 | 1603 | 0.090 |
Why?
|
| Humans | 22 | 2017 | 709431 | 0.090 |
Why?
|
| Indoles | 1 | 2017 | 1899 | 0.090 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2009 | 924 | 0.080 |
Why?
|
| Transcriptional Activation | 2 | 2005 | 1843 | 0.080 |
Why?
|
| Sulfonamides | 1 | 2017 | 1946 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 11384 | 0.080 |
Why?
|
| Structure-Activity Relationship | 2 | 2003 | 3221 | 0.080 |
Why?
|
| Gene Deletion | 1 | 2015 | 2858 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 3740 | 0.080 |
Why?
|
| Crosses, Genetic | 1 | 2007 | 847 | 0.070 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 660 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 2 | 2003 | 2853 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2006 | 423 | 0.070 |
Why?
|
| DNA Repair | 1 | 2015 | 2032 | 0.070 |
Why?
|
| Down-Regulation | 2 | 2003 | 3125 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2005 | 3901 | 0.070 |
Why?
|
| 3T3 Cells | 1 | 2006 | 1129 | 0.070 |
Why?
|
| NIH 3T3 Cells | 1 | 2006 | 695 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 1 | 2014 | 6768 | 0.060 |
Why?
|
| Epistasis, Genetic | 1 | 2006 | 375 | 0.060 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 5168 | 0.060 |
Why?
|
| Fluorouracil | 1 | 2008 | 1641 | 0.060 |
Why?
|
| Cells, Cultured | 2 | 2014 | 20303 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2008 | 2950 | 0.060 |
Why?
|
| Luciferases | 1 | 2005 | 765 | 0.060 |
Why?
|
| Rad52 DNA Repair and Recombination Protein | 1 | 2002 | 45 | 0.060 |
Why?
|
| Genes, abl | 1 | 2002 | 76 | 0.060 |
Why?
|
| Matrix Metalloproteinases | 1 | 2005 | 410 | 0.060 |
Why?
|
| Recombinant Proteins | 2 | 2003 | 6946 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 943 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2003 | 2909 | 0.060 |
Why?
|
| Hydrogen Peroxide | 1 | 2005 | 729 | 0.060 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2006 | 681 | 0.060 |
Why?
|
| Phosphotyrosine | 1 | 2002 | 473 | 0.050 |
Why?
|
| Ligases | 1 | 2003 | 357 | 0.050 |
Why?
|
| Genes, Reporter | 1 | 2005 | 1614 | 0.050 |
Why?
|
| Coculture Techniques | 1 | 2005 | 1382 | 0.050 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2002 | 430 | 0.050 |
Why?
|
| Cysteine Endopeptidases | 1 | 2003 | 670 | 0.050 |
Why?
|
| DNA Primers | 1 | 2005 | 3039 | 0.050 |
Why?
|
| Radiation Dosage | 1 | 2009 | 2044 | 0.050 |
Why?
|
| Oxidative Stress | 2 | 2015 | 3152 | 0.050 |
Why?
|
| Translocation, Genetic | 1 | 2005 | 1434 | 0.050 |
Why?
|
| Protein Interaction Mapping | 1 | 2003 | 642 | 0.050 |
Why?
|
| Multienzyme Complexes | 1 | 2003 | 835 | 0.040 |
Why?
|
| Cricetinae | 1 | 2002 | 2586 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2003 | 1553 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2003 | 1858 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2005 | 1682 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2005 | 1796 | 0.040 |
Why?
|
| RNA Interference | 1 | 2006 | 3027 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2003 | 3904 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2002 | 15286 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2003 | 1485 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2005 | 2118 | 0.040 |
Why?
|
| Doxorubicin | 1 | 2002 | 2238 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2005 | 2917 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 14353 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2003 | 3032 | 0.030 |
Why?
|
| RNA | 1 | 2005 | 2671 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2005 | 3556 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 18883 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2005 | 3688 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2003 | 3577 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2003 | 3060 | 0.030 |
Why?
|
| Models, Biological | 1 | 2008 | 9941 | 0.030 |
Why?
|
| Time Factors | 2 | 2003 | 41295 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2003 | 5136 | 0.020 |
Why?
|
| Mutation | 1 | 2015 | 29242 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2008 | 23044 | 0.020 |
Why?
|
| Rats | 1 | 2005 | 25068 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 2137 | 0.020 |
Why?
|
| Kidney | 1 | 2002 | 6872 | 0.020 |
Why?
|
| Neoplasms | 1 | 2014 | 20421 | 0.020 |
Why?
|
| Cell Survival | 1 | 2015 | 6184 | 0.020 |
Why?
|
| Female | 2 | 2014 | 377269 | 0.010 |
Why?
|
Concepts
(167)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(4)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_